Literature DB >> 11551670

[3H]dizocilpine binding to N-methyl-D-aspartate (NMDA) receptor is modulated by an endogenous Na+, K+-ATPase inhibitor. Comparison with ouabain.

A Reinés1, C Peña, G Rodríguez de Lores Arnaiz.   

Abstract

An endogenous Na+, K+-ATPase inhibitor termed endobain E has been isolated from rat brain which shares several biological properties with ouabain. This cardiac glycoside possesses neurotoxic properties attributable to Na+, K+-ATPase inhibition, which leads to NMDA receptor activation, thus supporting the concept that Na+/K+ gradient impairment has a critical impact on such receptor function. To evaluate potential direct effects of endobain E and ouabain on NMDA receptors, we assayed [3H]dizocilpine binding employing a system which excludes ionic gradient participation. Brain membranes thoroughly washed and stored as pellets ('non-resuspended' membranes) or after resuspension in sucrose ('resuspended' membranes) were employed. Membrane samples were incubated with 4 or 10 nM ligand with or without added endobain E or ouabain, in the presence of different glutamate plus glycine combinations, with or without spermidine. [3H]dizocilpine basal binding and Na+, K+- and Mg2+-ATPase activities proved very similar in 'non-resuspended' or 'resuspended' membranes. Endobain E decreased [3H]dizocilpine binding to 'resuspended' membranes in a concentration-dependent manner, attaining roughly 50% binding inhibition with the highest endobain E concentration assayed. Among tested conditions, only in 'resuspended' membranes, with 4 nM ligand and with 1x10(-8) M glutamate plus 1x10(-5) M glycine, was [3H]dizocilpine binding enhanced roughly +24% by ouabain (1 mM). After Triton X-100 membrane treatment, which drastically reduces Na+, K+-ATPase activity, the effect of ouabain on binding was lost whereas that of endobain E remained unaltered. Results indicate that not only membrane preparation but also treatment and storage are crucial to observe direct endobain E and ouabain effects on NMDA receptor, which are not attributable to changes in Na+, K+-ATPase activity or to Na+/K+ equilibrium alteration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551670     DOI: 10.1016/s0197-0186(01)00034-1

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  A comparative study between a brain Na+,K(+)-ATPase inhibitor (endobain E) and ascorbic acid.

Authors:  G Rodríguez de Lores Arnaiz; T Herbin; C Peña
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

2.  The effect of endogenous modulator endobain E on NMDA receptor is interfered by Zn2+ but is independent of modulation by spermidine.

Authors:  A Reinés; S Zárate; C Peña; G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

3.  Changes in Na+, K+-ATPase activity and alpha 3 subunit expression in CNS after administration of Na+, K+-ATPase inhibitors.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2010-11-16       Impact factor: 3.996

4.  The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2007-08-08       Impact factor: 3.996

5.  Functional Interaction Between Na/K-ATPase and NMDA Receptor in Cerebellar Neurons.

Authors:  Evgeny E Akkuratov; Olga M Lopacheva; Markus Kruusmägi; Alexandr V Lopachev; Zahoor A Shah; Alexander A Boldyrev; Lijun Liu
Journal:  Mol Neurobiol       Date:  2014-11-08       Impact factor: 5.590

6.  Intracerebroventricular administration of ouabain to rats changes the expression of NMDA receptor subunits in cerebral cortex and hippocampus.

Authors:  María Geraldina Bersier; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2009-03-26       Impact factor: 3.996

Review 7.  The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence.

Authors:  Paula F Kinoshita; Jacqueline A Leite; Ana Maria M Orellana; Andrea R Vasconcelos; Luis E M Quintas; Elisa M Kawamoto; Cristoforo Scavone
Journal:  Front Physiol       Date:  2016-06-02       Impact factor: 4.566

8.  Ouabain Modulates the Functional Interaction Between Na,K-ATPase and NMDA Receptor.

Authors:  Evgeny E Akkuratov; Linda Westin; Erika Vazquez-Juarez; Minttu de Marothy; Aleksandra K Melnikova; Hans Blom; Maria Lindskog; Hjalmar Brismar; Anita Aperia
Journal:  Mol Neurobiol       Date:  2020-07-10       Impact factor: 5.590

Review 9.  Na+/K+-pump and neurotransmitter membrane receptors.

Authors:  Arkady S Pivovarov; Fernando Calahorro; Robert J Walker
Journal:  Invert Neurosci       Date:  2018-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.